The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fraser Craig since 2013.
This trader's CIK number is 1557420.
At the time of last reporting, Fraser Craig was the President and CEO of Windtree Therapeutics Inc /de/. (stock ticker symbol WINT).
Also see all insider trading activities at Windtree Therapeutics Inc /de/.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | WINT | 5,431 | $4,942 | 0 | $0 | 0 | $0 |
| 2023 | WINT | 7,812 | $9,934 | 0 | $0 | 0 | $0 |
| 2022 | WINT | 21,500 | $11,616 | 0 | $0 | 0 | $0 |
| 2021 | WINT | 12,360 | $25,001 | 0 | $0 | 0 | $0 |
| 2020 | WINT | 3,919 | $23,978 | 0 | $0 | 0 | $0 |
| 2016 | WINT | 7,500 | $15,382 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | AEGR | 0 | $0 | 9,000 | $513,204 | 9,000 | $117,088 |
| 2013 | AEGR | 0 | $0 | 24,500 | $2,229,248 | 24,500 | $318,744 |
1. Windtree Therapeutics Inc /de/ (WINT)
2. Aegerion Pharmaceuticals, Inc. (AEGR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-08 | WINT | Buy | 5,431 | .91 | 4,942 |
| 2023-09-27 | WINT | Buy | 2,500 | 1.02 | 2,550 |
| 2023-09-26 | WINT | Buy | 2,500 | .90 | 2,250 |
| 2023-04-26 | WINT | Buy | 1,497 | 1.77 | 2,649 |
| 2023-04-25 | WINT | Buy | 1,315 | 1.89 | 2,485 |
| 2022-07-27 | WINT | Buy | 2,500 | .38 | 950 |
| 2022-07-26 | WINT | Buy | 2,500 | .37 | 935 |
| 2022-06-30 | WINT | Buy | 4,500 | .43 | 1,926 |
| 2022-06-29 | WINT | Buy | 7,000 | .41 | 2,905 |
| 2022-03-16 | WINT | Buy | 2,000 | .98 | 1,960 |
| 2022-03-15 | WINT | Buy | 3,000 | .98 | 2,940 |
| 2021-11-19 | WINT | Buy | 930 | 1.60 | 1,488 |
| 2021-11-18 | WINT | Buy | 930 | 1.61 | 1,497 |
| 2021-10-22 | WINT | Buy | 3,000 | 1.90 | 5,700 |
| 2021-10-19 | WINT | Buy | 3,000 | 1.91 | 5,730 |
| 2021-04-16 | WINT | Buy | 1,000 | 2.09 | 2,092 |
| 2021-04-15 | WINT | Buy | 1,000 | 2.24 | 2,240 |
| 2021-04-06 | WINT | Buy | 500 | 2.57 | 1,285 |
| 2021-04-05 | WINT | Buy | 1,000 | 2.58 | 2,580 |
| 2021-04-01 | WINT | Buy | 500 | 2.46 | 1,229 |
| 2021-03-31 | WINT | Buy | 500 | 2.32 | 1,160 |
| 2020-10-28 | WINT | Buy | 250 | 6.56 | 1,640 |
| 2020-10-09 | WINT | Buy | 250 | 5.83 | 1,456 |
| 2020-10-07 | WINT | Buy | 250 | 5.17 | 1,292 |
| 2020-05-22 | WINT | Buy | 2,069 | 7.25 | 15,000 |
| 2020-02-11 | WINT | Buy | 250 | 4.10 | 1,025 |
| 2020-02-10 | WINT | Buy | 250 | 4.10 | 1,025 |
| 2020-02-03 | WINT | Buy | 100 | 4.20 | 420 |
| 2020-02-04 | WINT | Buy | 500 | 4.24 | 2,120 |
| 2016-10-28 | WINT | Buy | 7,500 | 2.05 | 15,382 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-04-30 | AEGR | Sale | 2,250 | 43.54 | 97,965 |
| 2014-04-30 | AEGR | Option Ex | 2,250 | 13.01 | 29,272 |
| 2014-03-31 | AEGR | Sale | 2,250 | 46.52 | 104,663 |
| 2014-03-31 | AEGR | Option Ex | 2,250 | 13.01 | 29,272 |
| 2014-02-11 | AEGR | Option Ex | 2,250 | 13.01 | 29,272 |
| 2014-02-11 | AEGR | Sale | 2,250 | 67.00 | 150,750 |
| 2014-01-02 | AEGR | Option Ex | 2,250 | 13.01 | 29,272 |
| 2014-01-02 | AEGR | Sale | 2,250 | 71.03 | 159,826 |
| 2013-12-02 | AEGR | Sale | 2,250 | 70.60 | 158,847 |
| 2013-12-02 | AEGR | Option Ex | 2,250 | 13.01 | 29,272 |
| 2013-11-01 | AEGR | Option Ex | 2,250 | 13.01 | 29,272 |
| 2013-11-01 | AEGR | Sale | 2,250 | 83.17 | 187,121 |
| 2013-10-07 | AEGR | Option Ex | 20,000 | 13.01 | 260,200 |
| 2013-10-07 | AEGR | Sale | 20,000 | 94.16 | 1,883,280 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fraser Craig (President and CEO of Windtree Therapeutics Inc /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.